SUBSCRIBE
SUBSCRIBE
News   Policy

FDA Panel Rejects Protein Sciences Corporation’s Cell Culture Flu Vaccine, Wants More Safety Data

November 20, 2009 | 
1 min read

Bookmark and Share

Reuters -- More safety data would be needed before a new type of influenza vaccine made in insect cells should get approval, federal advisers said on Thursday.

Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Podcasts
COVID Reflections, Novo’s Next-Gen Weight Loss Struggles, Another Depression Miss, More
March 12, 2025
 · 
1 min read
 · 
Heather McKenzie
Close-Up Of Medicine Bottles Against Green Background
Opinion
FDA Faces Challenging Decision on Biomarker-Based Label Restrictions
March 10, 2025
 · 
5 min read
 · 
Harpreet Singh
A scientist with pill bottles in front of FDA headquarters
Regulatory
FDA Action Alert: GSK, Alnylam, Sanofi and More
March 10, 2025
 · 
7 min read
 · 
Tristan Manalac
Editorial
FDA Weathers Bait-and-Switch Storm as Staff and Sites Come and Go
March 7, 2025
 · 
3 min read
 · 
Jef Akst